Fovinaciclib citrate capsules | China Drugs List
Public reference information, not medical advice, a prescription or an offer to supply a medicine. Confirm current approval, availability and suitability with licensed professionals.
- Company
- Jinzhou Ahon Pharmaceutical Co., Ltd.
- Medicine type
- Chemical medicine
- Therapeutic area
- Oncology
- Indications recorded in the public source
- For adults with HR-positive, HER2-negative locally advanced or metastatic breast cancer: (1) with an aromatase inhibitor as initial endocrine therapy; or (2) with fulvestrant after progression on previous endocrine therapy.
- Indication source and scope
- Source date(s): 2026-04-27, 2026-10-23. Manufacturer prescribing information for Mainland China. Evidence review: 23 October 2026.
- Prescribing-information limitations
- Complete official prescribing information obtained. Mainland China label.
- China availability status
- Historical Chinese approval verified; current continuous market availability has not been checked for every product.
- Overseas status
- Market-by-market verification pending.
- Insurance classification
- Included in national insurance (Category B)
- Insurance edition
- 2025 edition; effective 1 January 2026
- Insurance restrictions
- Restricted to use with fulvestrant for adults with HR-positive, HER2-negative recurrent or metastatic breast cancer that has progressed after previous endocrine therapy.
- Insurance period
- 2026-01-01 to 2027-12-31
- Insurance verification notes
- Matched by exact or normalized ingredient/formulation name. Reimbursement still depends on the dosage form and listed payment restrictions.
Sources
- https://www.cde.org.cn/main/news/viewInfoCommon/b93aba16ec47467317057dca4aac8437
- https://www.nhsa.gov.cn/module/download/downfile.jsp?classid=0&filename=a32f9f2f3fc046afaf08471f87456ce3.pdf
- https://www.henlius.com/upload/202606/09/%E6%9E%B8%E6%A9%BC%E9%85%B8%E4%BC%8F%E7%BB%B4%E8%A5%BF%E5%88%A9%E8%83%B6%E5%9B%8A-%E8%AF%B4%E6%98%8E%E4%B9%A6.pdf
Open the interactive record, public price references and discussions